Streamline Health Solutions (NASDAQ:STRM) Coverage Initiated by Analysts at StockNews.com

Stock analysts at StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research note issued to investors on Saturday. The firm set a “sell” rating on the stock.

Separately, Craig Hallum upgraded Streamline Health Solutions to a “strong-buy” rating in a research note on Thursday, September 5th.

Streamline Health Solutions Stock Performance

Shares of STRM opened at $3.68 on Friday. The stock has a market capitalization of $15.72 million, a PE ratio of -0.74 and a beta of 1.67. The business’s fifty day moving average price is $2.84 and its 200 day moving average price is $5.03. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.61 and a quick ratio of 0.61. Streamline Health Solutions has a 12-month low of $1.85 and a 12-month high of $9.75.

Streamline Health Solutions (NASDAQ:STRM) last posted its quarterly earnings results on Monday, December 16th. The company reported ($0.61) earnings per share (EPS) for the quarter. Streamline Health Solutions had a negative return on equity of 44.85% and a negative net margin of 92.72%.

About Streamline Health Solutions

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.